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ORIGINAL ARTICLE
Endoscopic mucosal resection (EMR) is widely
accepted as a standard and useful treatment for
early gastric cancer (EGC).1,2 The original strip
biopsy technique was advocated by Tada et al in
1993.1 Modification of EMR by using a transparent
cap (EMR-C), which was later developed by Inoue
et al, was commonly used for treatment of early
gastroesophageal tumors.2 By using the strip biopsy
method and EMR-C, however, it remains difficult
to remove a gastroesophageal cancer with a diam-
eter greater than 2 cm and/or with ulceration or
submucosal fibrosis. Hosokawa et al developed a
new endoscopic knife, an insulation-tipped dia-
thermic knife (IT-knife), with a ceramic ball at the
top of the incising needle to prevent leakage of
electricity toward the deeper layer of the stomach.3
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Experiments with swine stomach have shown that
the IT-knife resects only the mucosal and submu-
cosal layers without histologically evident burning
effects in the serosa, and it is also possible to resect
canine gastric mucosa successfully in vivo. After
these promising experimental results in animal
models, the device was introduced into the clinic
in 1994.3 Miyamoto et al4 and Ono et al5 have
provided a better method for en bloc resection of
gastric neoplasms larger than 30 mm in size. The
definition, indication and application of endo-
scopic submucosal dissection (ESD) of early gas-
tric cancer (EGC) have been expanded by Gotoda
et al, at the National Cancer Center Hospital in
Japan.6 Although utilization of ESD in the treat-
ment of EGC has become very popular in Japan,
clinical experience and preliminary results of ESD
for gastric epithelial tumors have been reported
rarely outside Japan. Here, we report 70 patients
with gastric epithelial tumors that were resected
by ESD in a multicenter study in Taiwan.
Methods
Patients
We enrolled a total of 70 patients who received ESD
for gastric epithelial tumors between June 2004 and
August 2007. The indications for ESD followed
mainly the guidelines of Gotoda et al,6 except for
two patients with poorly differentiated adeno-
carcinoma who refused surgery. The diagnosis of
EGC was based on histologic confirmation of can-
cer invasion limited within the mucosal and sub-
mucosal layers. Forty patients received endoscopic
ultrasonography for staging work-up. The majority
of ESD procedures were performed at three med-
ical centers including Taipei Medical University
Hospital (10 cases), Chiayi Chang Gung Memorial
Hospital (32 cases) and Tri-Service General Hospi-
tal (16 cases). The rest of the ESD procedures were
performed at Taipei Veterans General Hospital
(four cases), E-Da Hospital (four cases), Changhua
Christian Hospital (two cases), National Taiwan
University Hospital (one case), and Kaohsiung
Chang Gung Memorial Hospital (one case).
Instruments
The instruments used for ESD included an endo-
scope and accessories, knife, and electrosurgical
unit. The IT-knife and needle knife (KD 610L and
KD-1L-1; Olympus Co. Ltd., Tokyo, Japan) were
utilized most often. The PSD-60 (Olympus) or
ICC-200 (ERBE, Tuebingen, Germany) were the
two most commonly used electrosurgical units. The
procedure was performed by using a conventional
single-channel endoscope (GIF-Q240, GIF-Q260;
Olympus). A hood (D−201-11802; Olympus)
was attached to the tip of the endoscope for the
submucosal dissection.
Procedure
The procedure of ESD is similar in all institutes in
Taiwan. A sample patient with EGC resected by
ESD is described here. Prior to ESD, chromoendo-
scopy with 0.2% indigo carmine was performed
to demarcate the margin of the gastric epithelial
tumor. Several spots were marked at 5–10 mm out-
side the margin of the gastric epithelial tumor by
using a needle knife to ensure a cancer-free margin.
Next, using a 23-gauge disposable injector, 1–4 mL
normal saline plus indigo carmine with 0.0025%
epinephrine were injected into the submucosa 
to lift the lesion. A circumferential incision was
made initially, followed by submucosal dissec-
tion with the IT-knife (Figures A–D). After ESD,
an intravenous proton pump inhibitor (PPI)
with a regular dose was given to all patients for 
3 days.
Tumor location was classified as being in the
upper, middle or lower third of the stomach.7 One-
piece resection was defined as en bloc resection.
Resection was considered to have a tumor-free
margin when the vertical and horizontal margins
were free of tumor cells.
Resected specimens were fixed on a board
with pins and cut into 2-mm slices according to
the Japanese Classification of Gastric Carcinoma.7
All specimens were evaluated histologically as to
whether tumorous glandular tissue was present at
the margin of each slice. Histopathologic diagno-
sis was based on the World Health Organization
(WHO) criteria (Figures E and F).
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Complications of ESD
Complications including massive bleeding and
perforation were recorded after ESD. Massive
bleeding was defined as blood loss > 500 mL.
Perforation was diagnosed when other organs,
extraluminal fat, or the extraluminal space were
observed endoscopically through the muscle layer
during ESD, irrespective of the presence of air 
accumulation in the abdomen, retroperitoneum
or mediastinum.
Figure. (A) 0.2% indigo carmine-aided chromoendoscopy demonstrated a 5×3cm IIa gastric epithelial tumor at the anterior
wall of the gastric antrum. (B) Circumferential incision for the gastric epithelial tumor. (C) ESD with a transparent hood.
(D) A 6 × 4 cm2 mucosal defect after ESD. (E) A 6 × 4 cm2 resected specimen fixed on a board with pins. (F) Pathology
showed a well-differentiated intramucosal cancer (hematoxylin & eosin, 40×).
A B
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Residual and recurrent tumors after ESD
Endoscopic re-examination was carried out every
2–3 months during the first year after ESD, every 6
months during the second year, and annually there-
after. In each endoscopic follow-up session, en-
doscopic biopsies were routinely taken from the
surrounding areas of previous ESD and any sus-
picious lesions nearby, and histologic examination
was carried out to identify any residual or recurrent
cancer.
Results
A total of 70 patients received ESD for gastric 
epithelial tumors; their demographic characteris-
tics are presented in Table 1. There were 45 men
and 25 women with a mean age of 66.5 years.
The majority of the tumors were located in the
middle (n = 14) and lower (n = 51) stomach. The
majority of the tumors were classified as flat, ele-
vated superficial cancer, type IIa (n = 33) and IIa +
IIc (n = 20), by endoscopic morphologic classifica-
tion. The mean diameter of the tumors was 1.85cm
and that of the resected specimens was 3.26 cm.
The depth of the gastric epithelial tumors was
evaluated after pathologic assessment: 64 tumors
were limited to the mucosal layer, two to the sub-
mucosal superficial layer (<500μm to the muscu-
lar muscle layer) and four to the deep submucosal
layer. According to the final pathologic classifica-
tion, the majority of EGCs resected were high-
grade dysplasia (n = 26) and well-differentiated
adenocarcinoma (n = 25). However, there were
12 tumors with low-grade dysplasia and two with
poorly differentiated adenocarcinoma resected
by ESD.
The one-piece resection rate with tumor-free
margins was 91.4% (64/70). There were six patients
who failed to be resected by en bloc resection.
There were three patients with perforation; one
patient with the tumor located at the posterior
wall of the gastric antrum, one with the tumor
located at the posterior wall of the middle gastric
body, and one with the tumor located near the
cardia. The median operation time was 92.4 min-
utes (range, 25–210 minutes). The median length
of stay was 8.7 days (range, 4–26 days).
The complications and local recurrence after
ESD are shown in Table 2. Four (5.7%) patients
had massive bleeding during ESD and only two
(2.8%) needed blood transfusions. The amount
of blood lost from these four patients was 600,
700, 1000 and 1200 mL, respectively. The last
two patients received blood transfusion after
ESD. There were three (4.3%) patients who had
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Table 1. Demographic characteristics of 70 patients
with gastric epithelial tumors who 
underwent endoscopic submucosal
dissection*
Age (yr) 66.5 ± 12.9 (35–84)
Gender (male/female) 45/25
Tumor location (upper 5/14/51
third/middle third/
lower third)
Tumor gross appearance 5/33/2/10/20
(I/IIa/IIb/IIc/IIa + IIc)
Tumor size (cm) 1.85 ± 0.81 (0.8–4.0)
Resected specimen 3.26 ± 1.39 (1.2–8.0)
size (cm)
Depth of tumor 64/6
(mucosa/submucosa)
Tumor pathology
Low-grade dysplasia 12
High-grade dysplasia 26
Well-differentiated 25
adenocarcinoma
Moderately-differentiated 5
adenocarcinoma
Poorly-differentiated 2
adenocarcinoma
*Data presented as mean ± standard deviation (range) or n.
Table 2. Complications and local recurrence after
endoscopic submucosal dissection*
Massive bleeding 4 (5.7)
Blood transfusion 2 (2.8)
Perforation 3 (4.3)
Emergent surgery 3 (4.3)
Local recurrent cancer 2 (2.8)
*Data presented as n (%).
the complication of perforation during ESD and
they were sent for emergent surgery. Among these,
two patients with upper gastric tumors and one
with a lower gastric tumor perforated after ESD.
The two perforated upper gastric tumors were a
2.5-cm and a 1.5-cm intramucosal cancer. The
one perforated lower gastric tumor was a 1.5-cm
submucosal cancer.
Curative treatment was defined as tumor-free
margins, including lateral and vertical margins,
no lymphovascular involvement, and tumor
depth limited to the submucosal superficial layer
(< 500 μm to the muscular muscle layer) after
pathologic assessment. Sixty-five (92.8%) pa-
tients had curative treatment with ESD for gastric
epithelial tumors. Five (7.2%) patients had non-
curative treatment with ESD. One of these five
patients had a cancer-involved vertical margin
and four had submucosal deep cancer. These five
patients were advised to undergo additional sur-
gery but they all refused because of comorbidity
with major systemic diseases, such as congestive
heart failure and chronic renal insufficiency.
Unfortunately, two (2.8%) patients had local re-
currence and then received surgery. None of the
patients died of gastric cancer-associated diseases
during the follow-up period. One patient died 8
months after ESD because of congestive heart
failure and another died 2 years after ESD be-
cause of a stroke. All the other patients (97.1%)
survived.
Discussion
Endoscopic resection is currently the treatment
of choice for EGC in Japan. Outside Japan, this
technique is increasingly gaining acceptance.8,9
Endoscopic resection offers similar efficacy to sur-
gery, and it is also minimally invasive. Endoscopic
resection for gastric tumors is superior to other
treatments such as argon plasma coagulation ther-
apy or photodynamic therapy because it allows
complete pathologic staging of the cancer after
the procedure.10 This is critical as it allows strat-
ification and refinement of further treatment.11
In comparison with the risk of morbidity and mor-
tality from surgery, patients with EGC who are 
at no or lower risk for developing lymph node
metastasis are ideal candidates for endoscopic
resection.12
EMR is accepted as an effective treatment for
EGC. However, the standard EMR technique is
usually inadequate for cancerous lesions greater
than 20 mm in diameter. The local recurrence rates
associated with incomplete EMR reported to
date have been high (9–18%).5,13,14 Incomplete
resection leading to recurrent cancer in the resid-
ual stomach therefore continues to be a difficult
problem.
ESD is superior to standard EMR because it
can be accomplished easily using a standard single-
channel gastroscope. ESD also has the advantage
of achieving large en bloc resection, which allows
precise histologic staging and reduced disease 
recurrence compared with standard EMR methods.
In this study, the mean size of the resected speci-
mens obtained was 3.26 cm and the mean size of
the tumors was 1.85 cm. We confirmed that ESD
can be utilized effectively to resect small superficial
gastric cancer with a diameter less than 2 cm.
One-piece resection of the gastric tumor is
important. It had lower local recurrence rate than
piecemeal resection for gastric cancer. The one-
piece resection rate in this study was (91.4%),
which is lower than that (94.2%) of Onozato 
et al.15 The reason for a lower one-piece resection
rate was possibly inexperience in dealing with
difficult locations of the gastric tumors.
Twelve gastric tumors, initially diagnosed as
EGC, turned out to be low-grade dysplasia after
resection and final pathologic examination. This
could be explained by the discrepancy between
different degrees of dysplasia and carcinoma, espe-
cially among various pathologists in the different
institutes. Second opinions from other patholo-
gists and unified pathologic criteria to define the
dysplasia and carcinoma in situ are therefore
needed before performing ESD. There were two
gastric tumors with poorly differentiated adeno-
carcinoma resected by ESD, which were contradic-
tory to the guidelines from the Japanese Gastric
C.C. Chang, et al
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Cancer Association.7 The indications of ESD
should be re-emphasized and strictly followed
by endoscopists and pathologists in Taiwan.
The perforation rate in this study was 4.3%,
which is similar to that (4%) of Gotoda’s study.16
Perforation in our patients occurred more fre-
quently in the tumors located in the upper stom-
ach. This situation has also been reported by
Gotoda.16 Although perforations can be temporar-
ily clipped by hemoclips, none of our endoscopists
performed this procedure to rescue perforations
because of inexperience and difficult tumor loca-
tions. The bleeding rate in this study was 5.7%,
which is less than that (7%) of Gotoda’s.16 Whether
intravenous proton pump inhibitors for the initial
3 days after ESD are beneficial in reducing the
bleeding rate requires to be confirmed by a larger
scale randomized study.
Apart from IT-ESD, there are other ESD tech-
niques that have been described, including the
hook knife,17 flex knife18 and the knife in a small
cap technique.19 Chiu et al have also reported safely
combining the use of these knives in dissecting
early neoplasia of the foregut.20
There were several limitations in the current
retrospective study. First, the case number in this
study was too small to make a final conclusion.
Second, this was a multicenter study. Different
skills, experience, learning curves, and attitudes
of endoscopists will give heterogeneous results.
The learning curve is crucial for endoscopists
performing ESD. Gotoda et al have advised that 
a trainee requires at least 30 cases to gain early
proficiency in this technique.21 Inexperienced
endoscopists may be associated with a higher
risk of procedure-related complications such as
bleeding and perforation, and also with a higher
risk of incomplete resection. Moreover, the pre-
existent differences in the interpretation of histo-
logic results among different pathologists will also
result in discrepancies before and after ESD.
In conclusion, ESD is a promising local curative
treatment option for EGC in Taiwan, but it still
carries risks of perforation and bleeding. The 
education and learning curve of endoscopists
will improve the outcome of this procedure.
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